(Q80332136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

main subject

endometrial carcinoma

1 reference

1 reference

1 reference

4

Hiroyuki Yoshikawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

7

Yuji Taketani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

5

Kei Kawana

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

Takahide Arimoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Shunsuke Nakagawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Toshiharu Yasugi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tetsu Yano

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

22 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

32-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

cites work

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Phase II evaluation of carboplatin in advanced endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

One-sample multiple testing procedure for phase II clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.038

10.1016/J.YGYNO.2006.07.038

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996113%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference